PPARG and neoplasm: Concurrently, EA inhibits adipocyte differentiation while promoting mesenchymal stem cell osteoblast differentiation by suppressing the transcriptional activity of PPARγ, a process that further disrupts tumor-associated metabolic reprogramming (65).